Back
Krystal Biotech Vs. ADMA Biologics Industry Stock Comparison
Sell
34
KRYS
Krystal Biotech
Last Price:
171.06
Seasonality Move:
17.47%
Buy
64
ADMA
ADMA Biologics
Last Price:
19.13
Seasonality Move:
4.64%
Sell
34
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $176.39. The Score for KRYS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $19.37. The Score for ADMA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $176.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $19.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADMA is experiencing slight buying pressure.
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2 | Sell |
| Relative Strength Index (14 RSI): | 47.3 | Sell |
| Chaikin Money Flow: | 286417 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (174.03 - 179.13) | Sell |
| Bollinger Bands (100): | (175.89 - 198.49) | Sell |
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 63.73 | Buy |
| Chaikin Money Flow: | 1841424 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.91 - 19.57) | Buy |
| Bollinger Bands (100): | (12.22 - 18.58) | Buy |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 175.09 | Buy |
| 20-day SMA: | 176.03 | Buy |
| 50-day SMA: | 183.43 | Sell |
| 200-day SMA: | 170.35 | Buy |
| 8-day EMA: | 175.5 | Buy |
| 20-day EMA: | 176.89 | Sell |
| 50-day EMA: | 180.88 | Sell |
| 200-day EMA: | 168.84 | Buy |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.66 | Buy |
| 20-day SMA: | 17.27 | Buy |
| 50-day SMA: | 17.9 | Buy |
| 200-day SMA: | 11.04 | Buy |
| 8-day EMA: | 17.09 | Buy |
| 20-day EMA: | 17.21 | Buy |
| 50-day EMA: | 17.06 | Buy |
| 200-day EMA: | 12.33 | Buy |
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.18 per share, and an increase next year of $2.01 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.18 per share.
Krystal Biotech Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ADMA Biologics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||